Nintedanib Gets Fast Track Designation for the Treatment of Scleroderma
source: pixabay.com

Nintedanib Gets Fast Track Designation for the Treatment of Scleroderma

According to a story from BioSpace, the U.S. Food and Drug Administration has given Fast Track designation for nintedanib, which is undergoing testing for the treatment of systemic sclerosis with…

Continue Reading Nintedanib Gets Fast Track Designation for the Treatment of Scleroderma
The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy
https://pixabay.com/en/approved-pass-ok-approval-symbol-1726357/

The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy

According to a story from raredr.com, The U.S. Food and Drug Administration (FDA) has recently approved Hizentra as a maintenance therapy for patients with chronic inflammatory demyelinating polyneuropathy. Hizentra is…

Continue Reading The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy
The FDA Puts a Halt to Trial for SGT-001, A Treatment in Development for Duchenne Muscular Dystrophy
source: pixabay.com

The FDA Puts a Halt to Trial for SGT-001, A Treatment in Development for Duchenne Muscular Dystrophy

According to a story from raredr.com, the FDA had to order the cessation of Phase II/III trials for the microdystrophin transfer therapy SGT-001, which was in development for the treatment…

Continue Reading The FDA Puts a Halt to Trial for SGT-001, A Treatment in Development for Duchenne Muscular Dystrophy
This Disease is Considered a “Delusion” by The Medical Community. A New Study Says It’s Not.
source: pixabay.com

This Disease is Considered a “Delusion” by The Medical Community. A New Study Says It’s Not.

According to a story from BioPortfolio, a recent study claims the Morgellons disease, a condition that has been shrouded in confusion and controversy, is not a delusion as some prior…

Continue Reading This Disease is Considered a “Delusion” by The Medical Community. A New Study Says It’s Not.
Children with Chronic Kidney Disease May Have Learning Problems Because of Dialysis
source: pixabay.com

Children with Chronic Kidney Disease May Have Learning Problems Because of Dialysis

According to a story from drugs.com, kids and teenagers with chronic kidney disease (CKD) may develop problems with learning and cognition, a new study suggests. Researchers emphasize that patients on…

Continue Reading Children with Chronic Kidney Disease May Have Learning Problems Because of Dialysis
Personal Independent Payment Assessments Are an Excuse to Strip Assistance Away From People With Disabilities
source: pixabay.com

Personal Independent Payment Assessments Are an Excuse to Strip Assistance Away From People With Disabilities

According to a story from The Independent, Britain's disability welfare program is coming under fire for its Personal Independent Payment (PIP) assessments. Statistical measures suggest that these assessments are taking…

Continue Reading Personal Independent Payment Assessments Are an Excuse to Strip Assistance Away From People With Disabilities
The FDA is Beginning to Accept New Endpoints and “Real World” Data in Clinical Trials
vitalworks / Pixabay

The FDA is Beginning to Accept New Endpoints and “Real World” Data in Clinical Trials

According to a story from Charcot-Marie-Tooth Disease News, the U.S. Food and Drug Administration (FDA), under the leadership of commissioner Scott Gottlieb, has begun to change clinical trials by accepting…

Continue Reading The FDA is Beginning to Accept New Endpoints and “Real World” Data in Clinical Trials
This Cancer Drug May Reduce Hearing Loss From Radiotherapy In Patients With Neurofibromatosis
RobinHiggins / Pixabay

This Cancer Drug May Reduce Hearing Loss From Radiotherapy In Patients With Neurofibromatosis

According to a story from Medical Xpress, the addition of crizotinib with radiation therapy could help reduce hearing loss associated with the treatment in patients with neurofibromatosis II. Crizotinib is…

Continue Reading This Cancer Drug May Reduce Hearing Loss From Radiotherapy In Patients With Neurofibromatosis
After Struggling With Juvenile Idiopathic Arthritis, An 11-Year-Old Girl Gains Access to Crucial Treatment
source: pixabay.com

After Struggling With Juvenile Idiopathic Arthritis, An 11-Year-Old Girl Gains Access to Crucial Treatment

According to a story from the Vancouver Sun, 11-year-old Jaylene Prime from British Columbia was able to obtain access to a critical treatment for her juvenile idiopathic arthritis. The drug,…

Continue Reading After Struggling With Juvenile Idiopathic Arthritis, An 11-Year-Old Girl Gains Access to Crucial Treatment
Inspired by Her Daughter, Mrs. South Africa Plans a Daring Climb to Promote Rare Disease Awareness
Source: Pixabay

Inspired by Her Daughter, Mrs. South Africa Plans a Daring Climb to Promote Rare Disease Awareness

According to a story from All4Women, Nicole Capper, crowned Mrs. South Africa, is planning to summit Mt. Everest, the highest mountain peak on the planet, in order to help promote…

Continue Reading Inspired by Her Daughter, Mrs. South Africa Plans a Daring Climb to Promote Rare Disease Awareness
Parkinson’s Disease Advocates Will Converge in DC For The Parkinson’s Policy Forum
source: pixabay.com

Parkinson’s Disease Advocates Will Converge in DC For The Parkinson’s Policy Forum

According to a story from markets.financialcontent.com, approximately 300 Parkinson's disease advocates and disease experts are slated to meet in Washington, DC for the Parkinson's Policy Forum. This year, the event…

Continue Reading Parkinson’s Disease Advocates Will Converge in DC For The Parkinson’s Policy Forum
A CRISPR Gene Editing Technique Could Fix Many of the Mutations Responsible For Duchenne Muscular Dystrophy
source: pixabay.com

A CRISPR Gene Editing Technique Could Fix Many of the Mutations Responsible For Duchenne Muscular Dystrophy

CRISPR gene editing technology is still mostly in its infancy, but the new tool is already causing a lot of excitement, particularly in the treatment of genetically-linked diseases. A recent…

Continue Reading A CRISPR Gene Editing Technique Could Fix Many of the Mutations Responsible For Duchenne Muscular Dystrophy
These Organizations Are Joining Forces To Use AI To Develop Improved Rare Disease Diagnostics
geralt / Pixabay

These Organizations Are Joining Forces To Use AI To Develop Improved Rare Disease Diagnostics

According to a story from PressReleasePoint, a new partnership has developed to generate artificial intelligence technology that will help diagnose people with a variety of rare diseases. The partnership consists…

Continue Reading These Organizations Are Joining Forces To Use AI To Develop Improved Rare Disease Diagnostics